原发性血小板增多症患者的18F-胆碱PET/CT超级扫描样表现
本文报道一例原发性血小板增多症(ET)患者在前列腺癌生化复发评估中行18F-胆碱PET/CT时偶然发现的超级扫描样表现;PSA轻度升高而后续68Ga-PSMA-11 PET/CT阴性,使弥漫性骨骼摄取被归因于 underlying hematologic disease 而非前列腺癌复发。
要点
- 原发性血小板增多症患者18F-胆碱PET/CT可呈超级扫描样弥漫骨骼摄取。
- PSA轻度升高而68Ga-PSMA-11 PET/CT阴性,支持骨骼摄取源于血液病而非前列腺癌复发。
- 18F-胆碱PET/CT在血液增殖性疾病中的潜在价值此前仅见少量临床与临床前报道。
核心结论
- 原发性血小板增多症患者的18F-胆碱PET/CT可表现为超级扫描样弥漫骨骼摄取,该摄取与 underlying hematologic disease 相关而非前列腺癌复发。
研究设计与样本
- 本文为病例报告,报道一例原发性血小板增多症患者因前列腺癌生化复发行18F-胆碱PET/CT的偶然发现。
主要发现
- 患者因前列腺癌生化复发行18F-胆碱PET/CT,偶然发现超级扫描样表现。
- PSA值轻度升高,后续68Ga-PSMA-11 PET/CT阴性。
- 上述结果使18F-胆碱PET/CT所见的弥漫性骨骼摄取被归因于 underlying hematologic disease 而非前列腺癌复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Few clinical and preclinical articles reported the potential usefulness of 18F-choline PET/CT in several hematological proliferative diseases. We report and incidental finding of a superscan-like pattern in a patient affected by essential thrombocythemia (ET), performing 18F-choline PET/CT for a biochemical recurrence of prostate cancer. The mild elevation of PSA values and the negativity of subsequent 68Ga-PSMA-11 PET/CT allowed to correlate the diffuse skeletal uptake detected on 18F-choline PET/CT to the underlying hematologic disease, rather than to a prostate cancer relapse.
引用
- Urso L, Nieri A, Borgia F, et al. Superscan-Like Pattern on 18F-Choline PET/CT in a Patient With Essential Thrombocythemia. Clin Nucl Med. 2022. PMID: 36723898. doi:10.1097/RLU.0000000000004474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。